Literature DB >> 30429159

Plateletpheresis-associated lymphopenia in frequent platelet donors.

John M Gansner1, Mahboubeh Rahmani2, A Helena Jonsson3, Brooke M Fortin4, Idayat Brimah5, Martha Ellis6, Robin Smeland-Wagman6, Zhihan J Li7, Jason M Schenkel8, Michael B Brenner3, Revital Yefidoff-Freedman1, Steven R Sloan8,9, Nancy Berliner1, Nicolas C Issa10, Lindsey R Baden10, Dan L Longo1, Duane R Wesemann3, Donna Neuberg11, Deepak A Rao3, Richard M Kaufman8.   

Abstract

More than 1 million apheresis platelet collections are performed annually in the United States. After 2 healthy plateletpheresis donors were incidentally found to have low CD4+ T-lymphocyte counts, we investigated whether plateletpheresis causes lymphopenia. We conducted a cross-sectional single-center study of platelet donors undergoing plateletpheresis with the Trima Accel, which removes leukocytes continuously with its leukoreduction system chamber. We recruited 3 groups of platelet donors based on the total number of plateletpheresis sessions in the prior 365 days: 1 or 2, 3 to 19, or 20 to 24. CD4+ T-lymphocyte counts were <200 cells per microliter in 0/20, 2/20, and 6/20 donors, respectively (P = .019), and CD8+ T-lymphocyte counts were low in 0/20, 4/20, and 11/20 donors, respectively (P < .001). The leukoreduction system chamber's lymphocyte-extraction efficiency was ∼15% to 20% for all groups. Immunophenotyping showed decreases in naive CD4+ T-lymphocyte and T helper 17 (Th17) cell percentages, increases in CD4+ and CD8+ effector memory, Th1, and regulatory T cell percentages, and stable naive CD8+ and Th2 percentages across groups. T-cell receptor repertoire analyses showed similar clonal diversity in all groups. Donor screening questionnaires supported the good health of the donors, who tested negative at each donation for multiple pathogens, including HIV. Frequent plateletpheresis utilizing a leukoreduction system chamber is associated with CD4+ and CD8+ T-cell lymphopenia in healthy platelet donors. The mechanism may be repeated extraction of these cells during plateletpheresis. The cytopenias do not appear to be harmful.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2018        PMID: 30429159      PMCID: PMC6367645          DOI: 10.1182/blood-2018-09-873125

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers.

Authors:  Allan B Dietz; Peggy A Bulur; Richard L Emery; Jeffrey L Winters; Dennis E Epps; Abba C Zubair; Stanimir Vuk-Pavlović
Journal:  Transfusion       Date:  2006-12       Impact factor: 3.157

2.  Recovery of white blood cells and platelets from leukoreduction system chambers of Trima Accel and COBE Spectra plateletpheresis devices.

Authors:  Erwin F Strasser; Thomas Weidinger; Robert Zimmermann; Jürgen Ringwald; Reinhold Eckstein
Journal:  Transfusion       Date:  2007-10       Impact factor: 3.157

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions.

Authors:  Anne F Eder; Beth A Dy; Barbara DeMerse; Stephen J Wagner; Susan L Stramer; E Mary O'Neill; Ross M Herron
Journal:  Transfusion       Date:  2017-09-06       Impact factor: 3.157

5.  Longterm maintenance of human naive T cells through in situ homeostasis in lymphoid tissue sites.

Authors:  Joseph J C Thome; Boris Grinshpun; Brahma V Kumar; Masa Kubota; Yoshiaki Ohmura; Harvey Lerner; Gregory D Sempowski; Yufeng Shen; Donna L Farber
Journal:  Sci Immunol       Date:  2016-12-02

6.  Immune system changes in cytapheresis donors.

Authors:  D A Senhauser; R G Westphal; J E Bohman; J C Neff
Journal:  Transfusion       Date:  1982 Jul-Aug       Impact factor: 3.157

7.  Lymphocytopenia in donors undergoing regular platelet apheresis with cell separators.

Authors:  G Robbins; C V Petersen; B Brozović
Journal:  Clin Lab Haematol       Date:  1985

8.  The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.

Authors:  Elie Richa; Paul Krueger; Edwin A Burgstaler; Sandra C Bryant; Jeffrey L Winters
Journal:  Transfusion       Date:  2008-03-13       Impact factor: 3.157

9.  A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.

Authors:  Nancy M Heddle; Morris A Blajchman; Ralph M Meyer; Jeff H Lipton; Irwin R Walker; Graham D Sher; Lorrie A Constantini; Bruce Patterson; Robin S Roberts; Kevin E Thorpe; Mark N Levine
Journal:  Transfusion       Date:  2002-05       Impact factor: 3.157

10.  Normal lymphocyte immunophenotype in an elderly population.

Authors:  Sâmia Macedo Queiroz Mota Castellão Tavares; Wilame de Lima Bravo Junior; Metton Ribeiro Lopes E Silva
Journal:  Rev Bras Hematol Hemoter       Date:  2014-04-04
View more
  4 in total

1.  CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.

Authors:  Mahboubeh Rahmani; Brooke M Fortin; Nancy Berliner; Nicolas Issa; Donna Neuberg; Richard M Kaufman; John M Gansner
Journal:  Transfusion       Date:  2019-02-12       Impact factor: 3.157

2.  Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach.

Authors:  Hao Yu; Fang Chen; Ka-On Lam; Li Yang; Yang Wang; Jian-Yue Jin; Aya Ei Helali; Feng-Ming Spring Kong
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

3.  Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study.

Authors:  Jingcheng Zhao; Erin Gabriel; Rut Norda; Petter Höglund; Lindsey Baden; Beatrice A Diedrich; Per Marits; Sara L Enoksson; John M Gansner; Richard Kaufman; Paul W Dickman; Gustaf Edgren
Journal:  Transfusion       Date:  2020-11-13       Impact factor: 3.157

4.  COVID-19 vaccine humoral response in frequent platelet donors with plateletpheresis-associated lymphopenia.

Authors:  Annemarie Eare Laumaea; Antoine Lewin; Debashree Chatterjee; Lorie Marchitto; Shilei Ding; Gabrielle Gendron-Lepage; Guillaume Goyette; Marie-Ève Allard; Carl Simard; Tony Tremblay; Josée Perreault; Ralf Duerr; Andrés Finzi; Renée Bazin
Journal:  Transfusion       Date:  2022-08-02       Impact factor: 3.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.